Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

Anti-obesity therapies

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Obesity prevalence in US adults (20–74 years).
Figure 2

References

  1. Daniels, J. Obesity: America's epidemic. Am. J. Nurs. 106, 40–49 (2006).

    Article  Google Scholar 

  2. Yanovski, S. Z. Pharmacotherapy for obesity — promise and uncertainty. N. Engl. J. Med. 353, 2187–2189 (2005).

    Article  CAS  Google Scholar 

  3. Pi-Sunyer, F. X. et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. J. Am. Med. Assoc. 295, 761–775 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Related links

Related links

FURTHER INFORMATION

American Obesity Association

ClinicalTrials.gov

NAASO, The Obesity Society

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melnikova, I., Wages, D. Anti-obesity therapies. Nat Rev Drug Discov 5, 369–370 (2006). https://doi.org/10.1038/nrd2037

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2037

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing